Interleukin 33: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 15:11, 17 March 2025
Interleukin 33 (IL-33) is a protein that in humans is encoded by the IL33 gene. IL-33 is a member of the interleukin family of cytokines that are involved in the immune response.
Function[edit]
IL-33 is a cytokine that binds to the ST2 receptor (a member of the Toll-like receptor superfamily) and is known to drive production of other cytokines (such as IL-4, IL-5, and IL-13) that induce T-helper cell type 2 (Th2) responses. It is expressed by various cell types, including fibroblasts, mast cells, and dendritic cells, and can be released upon cell death.
Clinical significance[edit]
IL-33 has been implicated in a variety of diseases, including asthma, rheumatoid arthritis, and cardiovascular disease. It is thought to play a role in the pathogenesis of these diseases by promoting inflammation and tissue damage.
See also[edit]
References[edit]
<references />
External links[edit]
- IL33 gene at NCBI
- IL-33 protein at UniProt


